Implementing a Program of Talimogene laherparepvec von Collichio, Frances, Burke, Lauren, Proctor, Amber, Wallack, Diana, Collichio, Anthony, Long, Patricia K., Ollila, David W.

Volltext

Multicenter phase 2 trial of the PARP inhibitor (PARPi) olaparib in recurrent IDH1 and IDH2-mutant contrast-enhancing glioma von Fanucci, Kristina, Pilat, Mary Josephine Paula, Shah, Ritu, Boerner, Scott Anthony, Li, Jing, Durecki, Diane E., Drappatz, Jan, Collichio, Frances A., Puduvalli, Vinay K., Lieberman, Frank S., Gonzalez, Javier, Giglio, Pierre, Bao, Xun, Ivy, S. Percy, Bindra, Ranjit, Omuro, Antonio Marcilio Padula, LoRusso, Patricia

Volltext

Axillary lymph node count is lower after neoadjuvant chemotherapy von Neuman, Heather, Carey, Lisa A., Ollila, David W., Livasy, Chad, Calvo, Benjamin F., Meyer, Anthony A., Kim, Hong Jin, Meyers, Michael O., Dees, E. Claire, Collichio, Fran A., Sartor, Carolyn I., Moore, Dominic T., Sawyer, Lynda R., Frank, Jill, Klauber-DeMore, Nancy

Volltext

High-resolution axillary ultrasound is a poor prognostic test for determining pathologic lymph node status in patients undergoing neoadjuvant chemotherapy for locally advanced brea... von Klauber-DeMore, Nancy, Kuzmiak, Cherie, Rager, Erika L., Ogunrinde, Oyinkansola B., Ollila, David W., Calvo, Benjamin F., Kim, Hong Jin, Meyer, Anthony, Dees, Claire, Graham, Mark, Collichio, Frances A., Sartor, Carolyn I., Metzger, Richard, Carey, Lisa A.

Volltext

Axillary lymph node count is lower after neoadjuvant chemotherapy. Commentary von NEUMAN, Heather, CAREY, Lisa A, SARTOR, Carolyn I, MOORE, Dominic T, SAWYER, Lynda R, FRANK, Jill, KLAUBER-DEMORE, Nancy, CALLCUT, Rachael A, BRESLIN, Tara M, OLLILA, David W, LIVASY, Chad, CALVO, Benjamin F, MEYER, Anthony A, HONG JIN KIM, MEYERS, Michael O, DEES, E. Claire, COLLICHIO, Fran A

Volltext